Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study

C. Pivonello; P. Rousaki; M. Negri; M. Sarnataro; M. Napolitano; F.Z. Marino; R. Patalano; M.C. De Martino; C. Sciammarella; A. Faggiano; G. Rocco; R. Franco; G.A. Kaltsas; A. Colao; R. Pivonello

doi:10.1007/s12020-016-1079-2

Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study

C. Pivonello, P. Rousaki, M. Negri, M. Sarnataro, M. Napolitano, F.Z. Marino, R. Patalano, M.C. De Martino, C. Sciammarella, A. Faggiano, G. Rocco, R. Franco, G.A. Kaltsas, A. Colao, R. Pivonello

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	603-620
Number of pages	18
Journal	Endocrine
Volume	56
Issue number	3
DOIs	https://doi.org/10.1007/s12020-016-1079-2
Publication status	Published - 2018

Access to Document

10.1007/s12020-016-1079-2

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989180854&doi=10.1007%2fs12020-016-1079-2&partnerID=40&md5=cf7442fc91949853859140ecd28ac462

Cite this

Pivonello, C., Rousaki, P., Negri, M., Sarnataro, M., Napolitano, M., Marino, F. Z., Patalano, R., De Martino, M. C., Sciammarella, C., Faggiano, A., Rocco, G., Franco, R., Kaltsas, G. A., Colao, A., & Pivonello, R. (2018). Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study. Endocrine, 56(3), 603-620. https://doi.org/10.1007/s12020-016-1079-2

Pivonello, C, Rousaki, P, Negri, M, Sarnataro, M, Napolitano, M, Marino, FZ, Patalano, R, De Martino, MC, Sciammarella, C, Faggiano, A, Rocco, G, Franco, R, Kaltsas, GA, Colao, A & Pivonello, R 2018, 'Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study', Endocrine, vol. 56, no. 3, pp. 603-620. https://doi.org/10.1007/s12020-016-1079-2

@article{25029bdbd853490ea6228487a7d7d422,

title = "Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study",

author = "C. Pivonello and P. Rousaki and M. Negri and M. Sarnataro and M. Napolitano and F.Z. Marino and R. Patalano and {De Martino}, M.C. and C. Sciammarella and A. Faggiano and G. Rocco and R. Franco and G.A. Kaltsas and A. Colao and R. Pivonello",

note = "Cited By :3 Export Date: 29 January 2019",

year = "2018",

doi = "10.1007/s12020-016-1079-2",

language = "English",

volume = "56",

pages = "603--620",

journal = "Endocrine",

issn = "1355-008X",

publisher = "Humana Press Inc.",

number = "3",

}

TY - JOUR

T1 - Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study

AU - Pivonello, C.

AU - Rousaki, P.

AU - Negri, M.

AU - Sarnataro, M.

AU - Napolitano, M.

AU - Marino, F.Z.

AU - Patalano, R.

AU - De Martino, M.C.

AU - Sciammarella, C.

AU - Faggiano, A.

AU - Rocco, G.

AU - Franco, R.

AU - Kaltsas, G.A.

AU - Colao, A.

AU - Pivonello, R.

N1 - Cited By :3 Export Date: 29 January 2019

PY - 2018

Y1 - 2018

U2 - 10.1007/s12020-016-1079-2

DO - 10.1007/s12020-016-1079-2

M3 - Article

SN - 1355-008X

VL - 56

SP - 603

EP - 620

JO - Endocrine

JF - Endocrine

IS - 3

ER -